About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 310 record(s)
Req # A-2021-068
Please send me the administrative documents (directives, regulations, procedures, proposed work methods, training materials, etc.) received from the Treasury Board Secretariat (TBS) or created by the Office of the Commissioner of Official Languages…Organization: Office of the Commissioner of Official Languages
February 2022
Req # A-2020-18439
Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10646
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8…Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021.…Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-058
I would like to know if there have been any complaints about the Canada-U.S. safe third country agreement and its negative impact on francophone communities outside Quebec. If there have been complaints, I would like to know how many there have been…Organization: Office of the Commissioner of Official Languages
January 2022
Req # A-2021-057
Any documents regarding the appointment or performance of Lionel Levert or Hubert Lussier, external consultants to the institution. These documents are likely held by the Human Resources Department. Without limiting the generality of the foregoing,…Organization: Office of the Commissioner of Official Languages
January 2022
Req # A-2021-066
"Any records (without limiting the generality of the foregoing, including emails, drafts, reports, briefing notes, presentations, text messages, voicemail messages, Teams messages, etc.) relating to the situation that occurred when XXXXX's…Organization: Office of the Commissioner of Official Languages
January 2022
Req # A-2021-065
"Any records (without limiting the generality of the foregoing, including emails, drafts, reports, briefing notes, presentations, text messages, voicemail messages, Teams messages, etc.) relating to the situation that occurred when, during a…Organization: Office of the Commissioner of Official Languages
January 2022
Req # A-2021-10762
Provide all emails, preparation documents, and similar materials that Douglas Clark and other PMPRB executives sent or received related to the recent statement given to the Hill Times for their May 25th article. Include, but do not limit the scope…Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-10767
Copies of all briefing material provided to Douglas Clark from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022